Entera Bio Ltd. (ENTX)

NASDAQ

$2.80

$-0.10

(-3.41%)

Pre-Market

Entera Bio Ltd. (ENTX) Live Price Chart

Last updated: ⁦2026-10-01 08:32:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Entera Bio Ltd. (ENTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2.80, with a market capitalization of $465.75M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.91 to $4.20. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$465.75M
Open	$2.90
Day's High	$10.16
Day's Low	$0.30
Previous Close	$2.91
Volume	10.00
Average Volume	1.81M
P/E Ratio	--
52-Week High	$4.20
52-Week Low	$0.91
Dividend Yield	--
Earnings Date	--

Entera Bio Ltd. (ENTX) Pre-Market Stock Price

Entera Bio Ltd. (ENTX) is trading at $2.80 in pre-market trading as of 2026-10-01 08:13:00, down 3.75% ($0.11) from the previous close of $2.91

Pre-market trading shows how investors are pricing ENTX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Entera Bio Ltd. (ENTX) 7-Day Stock Price Change

Over the past seven days, Entera Bio Ltd. (ENTX) moved from $2.98 to $2.80, representing a decline of 6.01% ($0.18).

The stock traded between $2.57 and $3.03 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 500.70 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ENTX 52-Week Price Position

Position in Range: 57.5%

52W Low$0.91

52W High$4.20

ENTX is currently trading at $2.80, placing it 57.5% of the way from its 52-week low of $0.91 to its 52-week high of $4.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Entera Bio Ltd. (ENTX)?

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Entera Bio Ltd. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	22
Exchange	NASDAQ
Company Website	https://www.enterabio.com

How to Buy Entera Bio Ltd. (ENTX) Stock on MEXC

Eligible investors can buy real shares of Entera Bio Ltd. (ENTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ENTX and Place Your Order

Open the RealStocks trading page and search for ENTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Entera Bio Ltd. (ENTX) stock price today?

Entera Bio Ltd. (ENTX) is currently trading at $ 2.80, down 3.75% ($0.11) from the previous close of $ 2.91. Intraday prices update in real time during regular trading hours.

2.Is ENTX stock going up or down today?

As of 2026-10-01 08:13:00, ENTX is trading at $ 2.80, down 3.75% ($0.11) from its previous close of $ 2.91. The stock has traded between $ 0.30 and $ 10.16 during today’s regular session. Past price movements do not guarantee future results.

3.What is ENTX pre-market price?

As of 2026-10-01 08:13:00, ENTX is trading at $ 2.80 in pre-market trading, down 3.75% ($0.11) from the previous close of $ 2.91. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ENTX after-hours price?

As of 2026-10-01 08:13:00, ENTX is trading at $ 2.92 in after-hours trading, up 0.38% ($0.01) from the regular-session close of $ 2.91. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ENTX stock trading now?

ENTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ENTX sit relative to its 52-week high and low?

Over the past 52 weeks, ENTX has traded between a low of $ 0.91 and a high of $ 4.20. At $ 2.80, the stock is positioned 57.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Entera Bio Ltd. in?

Entera Bio Ltd. (ENTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Entera Bio Ltd.'s market capitalization and where is it listed?

Entera Bio Ltd. is listed on the NASDAQ exchange with a market capitalization of $ 465.75M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ENTX valued in terms of P/E ratio and EPS?

ENTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.10. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Entera Bio Ltd. pay a dividend?

Entera Bio Ltd. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.